Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
10%
upside
8 price targets
|
0
%
|
|
|
|
10%
upside
7 price targets
|
0
%
|
|
|
|
10%
upside
7 price targets
|
0
%
|
|
|
1154
Arcutis Biotherapeutics
ARQT
$3.61B
|
10%
upside
3 price targets
|
0
%
|
|
|
10%
upside
6 price targets
|
0
%
|
|
|
|
10%
upside
7 price targets
|
0
%
|
|
|
|
10%
upside
5 price targets
|
0
%
|
|
|
|
10%
upside
10 price targets
|
0
%
|
|
|
|
10%
upside
13 price targets
|
0
%
|
|
|
|
10%
upside
3 price targets
|
0
%
|
|
|
1161
A.O. Smith
AOS
$9.55B
|
10%
upside
3 price targets
|
0
%
|
|
|
10%
upside
11 price targets
|
0
%
|
|
|
|
10%
upside
4 price targets
|
0
%
|
|
|
|
10%
upside
9 price targets
|
0
%
|
|
|
|
10%
upside
11 price targets
|
0
%
|
|
|
|
10%
upside
4 price targets
|
0
%
|
|
|
|
10%
upside
7 price targets
|
0
%
|
|
|
|
10%
upside
4 price targets
|
0
%
|
|
|
|
10%
upside
3 price targets
|
0
%
|
|
|
|
10%
upside
5 price targets
|
0
%
|
|
|
|
10%
upside
6 price targets
|
0
%
|
|
|
|
10%
upside
5 price targets
|
0
%
|
|
|
|
10%
upside
3 price targets
|
0
%
|
|
|
|
10%
upside
11 price targets
|
0
%
|
|
|
|
10%
upside
7 price targets
|
0
%
|
|